Greenwich Lifesciences Stock Market Value
| GLSI Stock | USD 14.25 0.32 2.20% |
| Symbol | Greenwich |
Greenwich Lifesciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Greenwich Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Greenwich Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Greenwich Lifesciences.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Greenwich Lifesciences on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Greenwich Lifesciences or generate 0.0% return on investment in Greenwich Lifesciences over 720 days. Greenwich Lifesciences is related to or competes with DiaMedica Therapeutics, Lyra Therapeutics, and Centessa Pharmaceuticals. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer imm... More
Greenwich Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Greenwich Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Greenwich Lifesciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.15 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 16.03 | |||
| Value At Risk | (4.90) | |||
| Potential Upside | 5.08 |
Greenwich Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Greenwich Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Greenwich Lifesciences' standard deviation. In reality, there are many statistical measures that can use Greenwich Lifesciences historical prices to predict the future Greenwich Lifesciences' volatility.| Risk Adjusted Performance | 0.0347 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.44) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0707 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Greenwich Lifesciences Backtested Returns
Greenwich Lifesciences is not too volatile at the moment. Greenwich Lifesciences holds Efficiency (Sharpe) Ratio of 0.0447, which attests that the entity had a 0.0447% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Greenwich Lifesciences, which you can use to evaluate the volatility of the firm. Please check out Greenwich Lifesciences' Downside Deviation of 3.15, risk adjusted performance of 0.0347, and Market Risk Adjusted Performance of 0.0807 to validate if the risk estimate we provide is consistent with the expected return of 0.14%. Greenwich Lifesciences has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.48, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Greenwich Lifesciences will likely underperform. Greenwich Lifesciences right now retains a risk of 3.2%. Please check out Greenwich Lifesciences value at risk, and the relationship between the jensen alpha and skewness , to decide if Greenwich Lifesciences will be following its current trending patterns.
Auto-correlation | -0.61 |
Very good reverse predictability
Greenwich Lifesciences has very good reverse predictability. Overlapping area represents the amount of predictability between Greenwich Lifesciences time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Greenwich Lifesciences price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Greenwich Lifesciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.61 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 6.21 |
Greenwich Lifesciences lagged returns against current returns
Autocorrelation, which is Greenwich Lifesciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Greenwich Lifesciences' stock expected returns. We can calculate the autocorrelation of Greenwich Lifesciences returns to help us make a trade decision. For example, suppose you find that Greenwich Lifesciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Greenwich Lifesciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Greenwich Lifesciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Greenwich Lifesciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Greenwich Lifesciences stock over time.
Current vs Lagged Prices |
| Timeline |
Greenwich Lifesciences Lagged Returns
When evaluating Greenwich Lifesciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Greenwich Lifesciences stock have on its future price. Greenwich Lifesciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Greenwich Lifesciences autocorrelation shows the relationship between Greenwich Lifesciences stock current value and its past values and can show if there is a momentum factor associated with investing in Greenwich Lifesciences.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:Check out Greenwich Lifesciences Correlation, Greenwich Lifesciences Volatility and Greenwich Lifesciences Alpha and Beta module to complement your research on Greenwich Lifesciences. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Greenwich Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.